Rocket List 2020

A curated list of the best fast-growing companies in London to work for. Built for job-seekers. Updated annually.

Built by Otta

We put the job seeker first, providing the most relevant and personalised job recommendations. Find jobs at all of the Rocket List companies on Otta.

The best startups to work for in London in 2020

allplants logo

allplants

Plant-powered, planet-kind dishes delivered to your door

Lifestyle
21-100
12m
Last 2 fundraises

20162017201820192020£3.5m£7.5m
Investors: Octopus Ventures, Isomer Capital, Felix Capital, Seedrs, Verlinvest, Otiva
Lifestyle
21-100
12m
Last 2 fundraises

20162017201820192020£3.5m£7.5m

Founders

Alex Petrides

(Co-founder)

5 years brand experience at PROPERCORN (also the first employee)

Jonathan Petrides

(Co-founder)

Founded Penda Health (healthcare company in Kenya) and Jipange KuSave (African mobile-based bank). Started his career as a consultant at McKinsey

Mission

Allplants is aiming to better our planet, by making eating more plants delicious, imaginative and easy. To start that journey, they're delivering hand-prepared meals to doorsteps UK-wide. Allplants is on a mission to inspire the next billion plant-powered people.

Otta's take on allplants

  • Allplants has found a niche within home food delivery, competing with the likes of Gousto and Hellofresh (albeit Allplants meals come prepared rather than as recipe boxes)
  • While vegans make up a smaller portion of the total market, the proportion of people trying to reduce their meat and dairy intake now makes up around 33% of people in the UK, giving them a big and growing market to tap into (especially as people trying to change their dieting habits are probably more likely to try new things)
  • The UK is also now the world leader for vegan food product launches, with 1 in 6 new food products coming to market claiming to be vegan. This is not just a London fad, with Allplants saying that only 38% of their customers are based in London.
  • As a certified B Corp, Allplants are taking their commitment to the environment seriously, and they’ve designed the packaging so it’s as environmentally-friendly as possible. They use offcuts of cotton denim from the factory floor to produce insulation, which goes in its cardboard boxes so it can be recycled and used again. This compares with the polystyrene boxes that are used for food logistics 90% of the time.
  • It will be important for Allplants to maintain high quality and a strong brand to build the defensibility of the business. It will be easy for bigger meal delivery companies to offer vegan alternatives, but not so easy for them to live up to Allplants environmental credentials.

allplants' take on their challenges in 2020

  • Whether it's the wonderful mouthwatering food we cook up every day and deliver to homes across the country, or the culture we instil at The Greenhouse (our home!), we're all about positive change at allplants
  • We're building the best team and everyone in our family brings something special to the table. 2020 is going to be a HUGE year for us with growth plans involving new products, markets and of course incredible people joining the team

Examples of people progressing

Top articles

How the food industry is serving up sustainability

An interview with Alex Petrides

Allplants is served £7.5M Series A funding

Vegan Food Company Raises £2 Million In 48 Hours


12M Employee Growth
87%
Gender Diversity
60% female

Last updated Dec 2019

This is the start of our stats on diversity, and we'll be including more in the future. We have gender data and want to use it to promote transparency. The data is according to our analysis, last updated Dec 2019.

allplants is hiring for 3 jobs on Otta!

More information
Babylon Health logo

Babylon Health

Accessible and affordable health care for everyone

Healthcare
501+
508m
Last 2 fundraises

20162017201820192020£440m£47m
Investors: Hoxton Ventures, Kinnevik, Vostok, PIF
Healthcare
501+
508m
Last 2 fundraises

20162017201820192020£440m£47m

Founders

Founder of Circle, Europe's largest partnership of clinicians. Previously Executive Director at Goldman Sachs

Mission

Babylon’s mission is to put an accessible and affordable health service in the hands of every person on earth.

Otta's take on Babylon Health

  • Babylon have a huge mission, to make health care accessible for all. This helped them attract a lot of funding and talent. In 2019 they raised $550m, the largest round ever for digital health delivery.
  • Making time to go and see the doctor can already be difficult, and often you have to wait over a week for an appointment. Bablyon's first step to making healthcare accessible is enabling people to interact with doctors over the phone or on video, a huge step change in convenience for the consumer.
  • Babylon says it delivers 4,000 clinical consultations each day and covers 4.3 million people worldwide, with more than 160,000 giving 5-star ratings for appointments. This traction certainly suggests they’re onto something.
  • Babylon partners with the NHS - one of the largest employers in the world and by far the biggest employer in the UK – and its staff and systems are stretched. It is turning to technology to help save time and redirect focus, but this process isn’t straightforward and will take time. Babylon is also looking to expand into the US and Asia, where the markets are larger but arguably even more complex given the regulatory environment.

Babylon Health's take on their challenges in 2020

  • Our biggest challenge for 2020 is to continue to address the global crisis in the healthcare system.
  • At present, even in the wealthiest parts of the world, healthcare services are difficult to access and unaffordable for many. In developing countries the situation is severe, with half of the population lacking essential services. At Babylon we believe everyone, everywhere, has the right to a long, healthy, happy life. We're working to make that possible, using the power of artificial intelligence and technology.
  • In other words, our mission is clear: We want to put an accessible and affordable health service into the hands of every person on Earth. We're partnering with governments, existing providers and insurers all over the world – from the UK and US, to Rwanda and South East Asia – to realise this ambition.
  • This year, we'll continue to grow rapidly, meaning we'll carry on recruiting ambitious, positive and empathetic people who want to make a difference in the world.

Examples of people progressing

Top articles

An interview with Babylon's CEO

Babylon CEO wants to make healthcare ‘accessible’ for all

The cautionary tale of how Babylon disrupted the NHS


12M Employee Growth
70%
Gender Diversity
40% female

Last updated Dec 2019

This is the start of our stats on diversity, and we'll be including more in the future. We have gender data and want to use it to promote transparency. The data is according to our analysis, last updated Dec 2019.

Babylon Health is hiring for 11 jobs on Otta!

More information
BenevolentAI logo

BenevolentAI

Applying AI to accelerate scientific discovery

Healthcare
101-200
234m
Last 2 fundraises

20162017201820192020£72m£92m
Investors: Goldman Sachs, Woodford Investment Management, Temasek
Healthcare
101-200
234m
Last 2 fundraises

20162017201820192020£72m£92m

Founders

Ken Mulvany

(Founder)

Previously CEO of Proximagen, a biotech company committed to delivering novel drugs and innovative new treatments for central nervous system disorders

Joanna Shields

(CEO, not founder)

Long career in technology, having previously worked at Google, Facebook and Bebo. Appointed to the House of Lords in 2014 and works as a Digital Economy Adviser to the UK Government

Mission

BenevolentAI's mission is to unlock the power of AI to transform drug discovery and bring effective medicines to every patient. Their vision is to drive transformational change through scalable technology solutions that result in a consistent pipeline of successful trials and new medicines for patients.

Otta's take on BenevolentAI

  • There is a lot of research being done in the pharmaceutical industry. BenevolentAI say there's a new research paper being published every 30 seconds. They argue this information is not being used in a smart way for the discovery and development of new drugs.
  • To tackle this problem, BenevolentAI uses artificial intelligence to analyse biomedical information, from clinical trials data to academic papers. They can then identify molecules that have failed in clinical trials and predict how these same compounds can instead be more efficient targeting other diseases.
  • They argue this approach can dramatically accelerate the discovery of new drugs. They've collaborated with large pharma companies like AstraZeneca and Johnson & Johnson subsidiary Janssen Pharmaceutica.
  • It's a big market, with Global Market Insights estimating the global healthcare AI market will exceed $10 billion by 2024. This gives them a big opportunity, but it won't be an easy problem to tackle.

BenevolentAI's take on their challenges in 2020

  • 90% of the world's data was produced in the last two years, and this rapid increase in data creation is felt most acutely in medical science. The sheer quantity of biomedical information available to scientists is increasing exponentially: from biomedical, genomic, patient, clinical trial and molecular data to consumer genetic data.
  • Although disease affects everyone and trillions have been spent on research and development, there are still thousands of diseases without any treatment. And, there are over 300 million people suffering from rare diseases that, unless we dramatically disrupt the economic and development models, there won't be a medicine developed for them anytime soon
  • Developing a drug and getting it to market can easily take 10-15 years at a cost of more than $2.5 billion. Furthermore, the Top Ten selling drugs that are on the market today only work on average for just 30-50% of the patients for which they are prescribed. The reason is because biology is incredibly complex and that the fact that the human body itself is one of the most complex data systems with over 37 trillion cells.
  • This represents a perfect opportunity for machine learning, which we continue to tackle at BenevolentAI.

Examples of people progressing

Top articles

This AI unicorn is disrupting the pharma industry in a big way

BenevolentAI starts AI collaboration with AstraZeneca

BenevolentAI draws $90M from Temasek


12M Employee Growth
14%
Gender Diversity
40% female

Last updated Dec 2019

This is the start of our stats on diversity, and we'll be including more in the future. We have gender data and want to use it to promote transparency. The data is according to our analysis, last updated Dec 2019.

BenevolentAI is hiring for 12 jobs on Otta!

More information

Back to top ↑

Our methodology

It's really tricky to pick a manageable number of companies to dig deep into, so we relied on three areas to reach our shortlist

  1. Plenty of jobs available. Given our list is for job-seekers, we looked closely at the number of roles available over recent months. We only want to show you the companies that are hiring in numbers
  2. High growth. It's hard to find a metric for growth to compare all companies. We considered the last two fundraises (£-value and date) as this data is readily available
  3. Strong investors. We know that not all great companies have great investors, but a strong investor (e.g. Index Ventures, who backed Facebook) is a useful signal that the company is going places. The investor will have done their homework to test the market, the business potential, the management team’s capabilities, etc

Thanks to breakoutlist.com for the inspiration!
Last updated: 14 January 2020

We'd love to chat

If you think we've got something wrong or want to add more information, please feel free to speak to us